178 related articles for article (PubMed ID: 15661431)
1. The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects.
Strigo IA; Duncan GH; Bushnell CM; Boivin M; Wainer I; Rodriguez Rosas EM; Persson J
Pain; 2005 Feb; 113(3):255-264. PubMed ID: 15661431
[TBL] [Abstract][Full Text] [Related]
2. Psychophysical analysis of visceral and cutaneous pain in human subjects.
Strigo IA; Bushnell CM; Boivin M; Duncan GH
Pain; 2002 Jun; 97(3):235-246. PubMed ID: 12044620
[TBL] [Abstract][Full Text] [Related]
3. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.
Persson J; Hasselström J; Wiklund B; Heller A; Svensson JO; Gustafsson LL
Acta Anaesthesiol Scand; 1998 Aug; 42(7):750-8. PubMed ID: 9698948
[TBL] [Abstract][Full Text] [Related]
4. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.
Kvarnström A; Karlsten R; Quiding H; Gordh T
Acta Anaesthesiol Scand; 2004 Apr; 48(4):498-506. PubMed ID: 15025615
[TBL] [Abstract][Full Text] [Related]
5. Cortical processing of visceral and somatic stimulation: differentiating pain intensity from unpleasantness.
Dunckley P; Wise RG; Aziz Q; Painter D; Brooks J; Tracey I; Chang L
Neuroscience; 2005; 133(2):533-42. PubMed ID: 15896917
[TBL] [Abstract][Full Text] [Related]
6. Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).
Lemming D; Sörensen J; Graven-Nielsen T; Lauber R; Arendt-Nielsen L; Gerdle B
Eur J Pain; 2007 Oct; 11(7):719-32. PubMed ID: 17197214
[TBL] [Abstract][Full Text] [Related]
7. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.
Eide PK; Stubhaug A; Stenehjem AE
Neurosurgery; 1995 Dec; 37(6):1080-7. PubMed ID: 8584148
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.
Hughes AM; Rhodes J; Fisher G; Sellers M; Growcott JW
Br J Clin Pharmacol; 2002 Jun; 53(6):604-12. PubMed ID: 12047485
[TBL] [Abstract][Full Text] [Related]
9. Do we perceive sensations inside and outside of our body differently? Perceptual, emotional, and behavioral differences between visceral and somatic sensation, discomfort, and pain.
Guadagnoli L; Hoffert Y; Den Hond S; Dreesen E; van Ryckeghem D; Van Damme S; Zaman J; Van Oudenhove L
Neurogastroenterol Motil; 2024 Jun; 36(6):e14787. PubMed ID: 38523349
[TBL] [Abstract][Full Text] [Related]
10. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
11. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor.
Willert RP; Woolf CJ; Hobson AR; Delaney C; Thompson DG; Aziz Q
Gastroenterology; 2004 Mar; 126(3):683-92. PubMed ID: 14988822
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain.
Kvarnström A; Karlsten R; Quiding H; Emanuelsson BM; Gordh T
Acta Anaesthesiol Scand; 2003 Aug; 47(7):868-77. PubMed ID: 12859309
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
14. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.
Wallace MS; Ridgeway B; Leung A; Schulteis G; Yaksh TL
J Clin Pharmacol; 2002 Jan; 42(1):70-80. PubMed ID: 11808827
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of visceral and cutaneous pain in the human brain.
Strigo IA; Duncan GH; Boivin M; Bushnell MC
J Neurophysiol; 2003 Jun; 89(6):3294-303. PubMed ID: 12611986
[TBL] [Abstract][Full Text] [Related]
16. An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.
Sigtermans M; Noppers I; Sarton E; Bauer M; Mooren R; Olofsen E; Dahan A
Eur J Pain; 2010 Mar; 14(3):302-7. PubMed ID: 19540140
[TBL] [Abstract][Full Text] [Related]
17. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients.
Graven-Nielsen T; Kendall SA; Henriksson KG; Bengtsson M; Sörensen J; Johnson A; Gerdle B; Arendt-Nielsen L
Pain; 2000 Apr; 85(3):483-491. PubMed ID: 10781923
[TBL] [Abstract][Full Text] [Related]
18. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
[TBL] [Abstract][Full Text] [Related]
19. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.
Pöyhiä R; Vainio A
Clin J Pain; 2006 Jan; 22(1):32-6. PubMed ID: 16340591
[TBL] [Abstract][Full Text] [Related]
20. Postdelivery of alfentanil and ketamine has no effect on intradermal capsaicin-induced pain and hyperalgesia.
Wallace MS; Braun J; Schulteis G
Clin J Pain; 2002; 18(6):373-9. PubMed ID: 12441831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
